Want to join the conversation?
$FLIR 2Q15 Q&A: Quillin of Stephens Inc. asked about comparisons on GM QoverQ. Tom answered that big impact for YoverY was the FX impact. In sequential, had strong GM in 1Q15. Product mix is always going to have a large impact on GM. Specific things occurred in various segments that all brought GM down a little bit.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?